XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating Activities    
Net loss $ (22,956) $ (137,942)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 40,570 40,699
Amortization of deferred financing costs 1,749 595
Credit loss (reversal) expense, net (4,884) 15,582
Write-downs 878 13,339
Deferred income tax (benefit) expense (1,687) 23,142
Share-based and other non-cash compensation 18,558 16,345
Unrealized foreign currency exchange loss (gain) 555 (394)
Realized and unrealized investment (gains) losses (5,311) 939
Equity in losses of investees 0 1,858
Changes in assets and liabilities:    
Accounts receivable (24,336) 30,350
Inventories 653 (10,278)
Film assets (10,035) (6,177)
Deferred revenue (1,434) 5,233
Changes in other operating assets and liabilities (11,902) (24,109)
Net cash used in operating activities (19,582) (30,818)
Investing Activities    
Purchase of property, plant and equipment (2,353) (658)
Investment in equipment for joint revenue sharing arrangements (5,361) (5,289)
Acquisition of other intangible assets (3,399) (1,661)
Proceeds from sale of equity investment 17,769  
Net cash provided by (used in) investing activities 6,656 (7,608)
Financing Activities    
Proceeds from issuance of convertible notes, net 223,675  
Debt issuance costs related to convertible notes (1,163)  
Purchase of capped calls related to convertible notes (19,067)  
Revolving credit facility borrowings 3,600 280,244
Repayments of revolving credit facility borrowings (300,243)  
Credit facility amendment fees paid (474) (1,026)
Repurchase of common shares (4,610) (36,624)
Treasury stock purchased for future settlement of restricted share units   3,086
Taxes withheld and paid on employee stock awards vested (3,045) (251)
Common shares issued - stock options exercised 883  
Dividends paid to non-controlling interests (5,027) (4,214)
Net cash (used in) provided by financing activities (110,487) 233,509
Effects of exchange rate changes on cash (958) 630
(Decrease) increase in cash and cash equivalents during period (124,371) 195,713
Cash and cash equivalents, beginning of period 317,379 109,484
Cash and cash equivalents, end of period 193,008 305,197
IMAX China    
Financing Activities    
Repurchase of common shares $ (5,016) $ (1,534)